ArticleFuture oncology (London, England)2025
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed
Paresh Vyas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it